At the American Society of Hematology (ASH) Annual Meeting and Exposition (December 1-4, 2018; San Diego, CA), Journal of Clinical Pathways spoke with Chadi Nabhan, MD, Cardinal Health, regarding the adverse events, patterns of TLS prophylaxis and management, and dosing patterns in patients with CLL treated in community and academic settings.
